Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Blackledge G, Lawton F, Redman C, Kelly K (1989) Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and design of phase II trials. Br J Cancer 59: 650–653
2. Brodovsky HS, Bauer M, Horton J, Elson PJ (1984) Comparison of melphalan with cyclophosphamide, methotrexate and 5-fluorouracil in patients with ovarian cancer. Cancer 53: 844–852
3. Gore M (2001) Treatment of Relapsed Epithelial Ovarian Cancer, pp 468–476, ASCO Educational Book Spring. Lippincott Williams and Wilkins, Philadelphia
4. Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA: Cancer J Clin 51: 15–36
5. Klaassen D, Shelley W, Starreveld A, Kirk M, Boyes D, Gerulath A, Levitt M, Fraser R, Carmichael J, Methot Y (1988) Early stage ovarian cancer: a randomised clinical trial comparing whole abdominal radiotherapy, melphalan and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report. J Clin Oncol 6: 1254–1263
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献